{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T03:37:04Z","timestamp":1794109024391,"version":"4.8.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T00:00:00Z","timestamp":1717372800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000266","name":"Engineering and Physical Sciences Research Council","doi-asserted-by":"publisher","award":["EP\/R035164\/1"],"award-info":[{"award-number":["EP\/R035164\/1"]}],"id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000266","name":"Engineering and Physical Sciences Research Council","doi-asserted-by":"publisher","award":["EP\/L015110\/1"],"award-info":[{"award-number":["EP\/L015110\/1"]}],"id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000360","name":"Scottish Funding Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000360","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010749","name":"Comiss\u00e3o Nacional de Energia Nuclear","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010749","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["465763\/2014-6"],"award-info":[{"award-number":["465763\/2014-6"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["440228\/2021-2"],"award-info":[{"award-number":["440228\/2021-2"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.biopha.2024.116881","type":"journal-article","created":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T03:35:44Z","timestamp":1719200144000},"page":"116881","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Photodynamic therapy offers a novel approach to managing miltefosine-resistant cutaneous leishmaniasis"],"prefix":"10.1016","volume":"177","author":[{"given":"Fernanda V.","family":"Cabral","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Riahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saydulla","family":"Persheyev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Cortez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ifor D.W.","family":"Samuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha S.","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2024.116881_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0223313","article-title":"The impact of leishmaniasis on mental health and psychosocial well-being: a systematic review","volume":"14","author":"Pires","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2024.116881_bib2","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(18)31204-2","article-title":"Leishmaniasis.","volume":"392","author":"Burza","year":"2018","journal-title":"Lancet (Lond., Engl. )"},{"key":"10.1016\/j.biopha.2024.116881_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006052","article-title":"Drug resistance and treatment failure in leishmaniasis: A 21st century challenge","volume":"11","author":"Ponte-Sucre","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.biopha.2024.116881_bib4","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2018-000709","article-title":"Why miltefosine\u2014a life-saving drug for leishmaniasis\u2014is unavailable to people who need it the most","volume":"3","author":"Sunyoto","year":"2018","journal-title":"BMJ Glob. Health"},{"key":"10.1016\/j.biopha.2024.116881_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2021.106459","article-title":"An update on the clinical pharmacology of miltefosine in the treatment of leishmaniasis","volume":"59","author":"Pali\u0107","year":"2022","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.biopha.2024.116881_bib6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1128\/AAC.50.1.73-79.2006","article-title":"In vitro and in vivo interactions between miltefosine and other antileishmanial drugs","volume":"50","author":"Seifert","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biopha.2024.116881_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fitd.2022.837460","article-title":"Tackling drug resistance and other causes of treatment failure in leishmaniasis","volume":"3","author":"Wijnant","year":"2022","journal-title":"Front. Trop. Dis."},{"key":"10.1016\/j.biopha.2024.116881_bib8","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1039\/b311900a","article-title":"Photodynamic therapy: a new antimicrobial approach to infectious disease?","volume":"3","author":"Hamblin","year":"2004","journal-title":"Photochem. Photobiol. Sci."},{"key":"10.1016\/j.biopha.2024.116881_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.jphotobiol.2020.111893","article-title":"Global priority multidrug-resistant pathogens do not resist photodynamic therapy","author":"Sabino","year":"2020","journal-title":"J. Photochem. Photobiol. B."},{"key":"10.1016\/j.biopha.2024.116881_bib10","article-title":"Photodynamic therapy for treating infected skin wounds: a systematic review and meta-analysis from randomized clinical trials","volume":"40","author":"Oliveira","year":"2022","journal-title":"Photo Photo Ther."},{"key":"10.1016\/j.biopha.2024.116881_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114949","article-title":"Synergistic effect of Ru(II)-based type II photodynamic therapy with cefotaxime on clinical isolates of ESBL-producing Klebsiella pneumoniae.","volume":"164","author":"Hormaz\u00e1bal","year":"2023","journal-title":"Biomed. Pharm."},{"issue":"2","key":"10.1016\/j.biopha.2024.116881_bib12","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3390\/ijms19020337","article-title":"An in vitro study on the effect of combined treatment with photodynamic and chemical therapies on Candida albicans","volume":"19","author":"Hsieh","year":"2018","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2024.116881_bib13","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jphotobiol.2016.02.036","article-title":"Synergistic antimicrobial effect of photodynamic therapy and ciprofloxacin","volume":"158","author":"Ronqui","year":"2016","journal-title":"J. Photochem. Photobio. B"},{"key":"10.1016\/j.biopha.2024.116881_bib14","doi-asserted-by":"crossref","first-page":"717","DOI":"10.3390\/jof9070717","article-title":"New insights in phenothiazinium-mediated photodynamic inactivation of Candida auris","volume":"9","author":"Silva","year":"2023","journal-title":"J. Fungi."},{"key":"10.1016\/j.biopha.2024.116881_bib15","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jphotobiol.2006.07.005","article-title":"Phenothiazinium derivatives for pathogen inactivation in blood products","volume":"86","author":"Wainwright","year":"2007","journal-title":"J. Photochem. Photobiol. B."},{"key":"10.1016\/j.biopha.2024.116881_bib16","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adh8619","article-title":"OLED catheters for inner-body phototherapy: a case of type 2 diabetes mellitus improved via duodenal photobiomodulation","volume":"9","author":"Sim","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.biopha.2024.116881_bib17","doi-asserted-by":"crossref","first-page":"2204622","DOI":"10.1002\/advs.202204622","article-title":"Wearable photomedicine for neonatal jaundice treatment using blue organic light-emitting diodes (OLEDs): toward textile-based wearable phototherapeutics","volume":"9","author":"Choi","year":"2022","journal-title":"Adv. Sci."},{"key":"10.1016\/j.biopha.2024.116881_bib18","doi-asserted-by":"crossref","first-page":"2100806","DOI":"10.1002\/admt.202100806","article-title":"Organic light-emitting diode based fluorescence sensing system for DNA detection","volume":"7","author":"Lian","year":"2022","journal-title":"Adv. Mater. Technol."},{"key":"10.1016\/j.biopha.2024.116881_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002999","article-title":"In vitro and in vivo miltefosine susceptibility of a Leishmania amazonensis isolate from a patient with diffuse cutaneous leishmaniasis","volume":"8","author":"Coelho","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.biopha.2024.116881_bib20","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.mimet.2013.02.007","article-title":"Parasite burden in Leishmania (Leishmania) amazonensis-infected mice: validation of luciferase as a quantitative tool","volume":"93","author":"Reimao","year":"2013","journal-title":"J. Microbiol. Methods"},{"key":"10.1016\/j.biopha.2024.116881_bib21","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/php.13188","article-title":"Preclinical investigation of methylene blue-mediated antimicrobial photodynamic therapy on Leishmania parasites using real-time bioluminescence","volume":"96","author":"Cabral","year":"2020","journal-title":"Photochem. Photobiol."},{"key":"10.1016\/j.biopha.2024.116881_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneumeth.2014.04.017","article-title":"Building, testing and validating a set of home-made von Frey filaments: A precise, accurate and cost effective alternative for nociception assessment","volume":"232","author":"De Sousa","year":"2014","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.biopha.2024.116881_bib23","doi-asserted-by":"crossref","first-page":"2100395","DOI":"10.1002\/admt.202100395","article-title":"Organic light-emitting diodes as an innovative approach for treating cutaneous Leishmaniasis","volume":"6","author":"Cabral","year":"2021","journal-title":"Adv. Mater. Technol."},{"key":"10.1016\/j.biopha.2024.116881_bib24","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/php.12264","article-title":"Membrane damage efficiency of phenothiazinium photosensitizers","volume":"90","author":"Bacellar","year":"2014","journal-title":"Photochem. Photobiol."},{"key":"10.1016\/j.biopha.2024.116881_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000179","article-title":"Control of parasitophorous vacuole expansion by LYST\/Beige restricts the intracellular growth of Leishmania amazonensis","volume":"4","author":"Wilson","year":"2008","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.biopha.2024.116881_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/1040841X.2018.1467876","article-title":"Antimicrobial photodynamic therapy - what we know and what we don\u2019t.","volume":"44","author":"Cieplik","year":"2018","journal-title":"Crit. Rev. Microbiol."},{"key":"10.1016\/j.biopha.2024.116881_bib27","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/nrmicro2608","article-title":"Leishmaniasis: complexity at the host-pathogen interface","volume":"9","author":"Kaye","year":"2011","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.biopha.2024.116881_bib28","article-title":"Chlorin e6-induced photodynamic effect polarizes the macrophage into an M1 phenotype through oxidative DNA damage and activation of STING","volume":"13","author":"Yu","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2024.116881_bib29","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.pdpdt.2010.04.004","article-title":"Can surgical site infections be treated by photodynamic therapy?","volume":"7","author":"Hamblin","year":"2010","journal-title":"Photo Photodyn. Ther."},{"key":"10.1016\/j.biopha.2024.116881_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.jphotobiol.2021.112236","article-title":"Towards effective cutaneous leishmaniasis treatment with light-based technologies. A systematic review and meta-analysis of preclinical studies","volume":"221","author":"Cabral","year":"2021","journal-title":"J. Photochem. Photobiol. B Biol."},{"key":"10.1016\/j.biopha.2024.116881_bib31","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/lsm.20922","article-title":"Photodynamic inactivation of Acinetobacter baumannii using phenothiazinium dyes: in vitro and in vivo studies","volume":"42","author":"Rag\u00e0s","year":"2010","journal-title":"Lasers Surg. Med."},{"key":"10.1016\/j.biopha.2024.116881_bib32","doi-asserted-by":"crossref","first-page":"551","DOI":"10.2307\/3579621","article-title":"A theoretical study of light fractionation and dose-rate effects in photodynamic therapy","volume":"147","author":"Pogue","year":"1997","journal-title":"Radiat. Res."},{"key":"10.1016\/j.biopha.2024.116881_bib33","doi-asserted-by":"crossref","DOI":"10.1038\/nri.2016.72","article-title":"Cutaneous leishmaniasis: immune responses in protection and pathogenesis","volume":"16","author":"Scott","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2024.116881_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113941","article-title":"Photodynamic and antibiotic therapy in combination against bacterial infections: efficacy, determinants, mechanisms, and future perspectives","volume":"177","author":"Feng","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biopha.2024.116881_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003889","article-title":"A review: the current in vivo models for the discovery and utility of new anti-leishmanial drugs targeting cutaneous leishmaniasis","volume":"9","author":"Mears","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.biopha.2024.116881_bib36","doi-asserted-by":"crossref","first-page":"e02507","DOI":"10.1128\/AAC.02507-18","article-title":"Systematic review of host-mediated activity of miltefosine in leishmaniasis through immunomodulation","volume":"63","author":"Pali\u0107","year":"2019","journal-title":"Antimicrob. Agents Chemother."}],"updated-by":[{"DOI":"10.1016\/j.biopha.2026.119495","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000}},{"DOI":"10.1016\/j.biopha.2026.119495","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000}}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224007650?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224007650?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T20:02:25Z","timestamp":1782849745000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224007650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":36,"alternative-id":["S0753332224007650"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116881","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Photodynamic therapy offers a novel approach to managing miltefosine-resistant cutaneous leishmaniasis","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116881","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116881"}}